Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-05-10
2011-05-10
Kemmerer, Elizabeth C. (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S007600, C514S019300, C424S130100, C424S133100, C424S141100, C424S143100, C424S145100, C530S350000
Reexamination Certificate
active
07939497
ABSTRACT:
This invention is generally in the field of methods for diagnosis, treatment and prevention of various disorders involving the Slit2 mediated angiogenesis.
REFERENCES:
patent: 5593990 (1997-01-01), D'Amato
patent: 5629327 (1997-05-01), D'Amato
patent: 5686102 (1997-11-01), Gross et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 5712291 (1998-01-01), D'Amato
patent: 5736154 (1998-04-01), Fuisz
patent: 5741511 (1998-04-01), Lee et al.
patent: 5869305 (1999-02-01), Samulski et al.
patent: 5886039 (1999-03-01), Kock et al.
patent: 5888767 (1999-03-01), Dropulić et al.
patent: 5941868 (1999-08-01), Kaplan et al.
patent: 5962274 (1999-10-01), Parks
patent: 6197801 (2001-03-01), Lin
patent: 6258374 (2001-07-01), Friess et al.
patent: 2002/0044919 (2002-04-01), Yu
patent: WO 9920764 (1999-04-01), None
patent: WO 00/58335 (2000-10-01), None
patent: WO-2004/046191 (2004-06-01), None
Geng et al., FASEB J. Mar. 7, 2001, vol. 15(4): p. A8, abstract 6.22.
Phillip S., Cancer Pract. May-Jun. 2000, vol. 8(3): pp. 148-1451.
Phillip, S., Cancer Practice, 2000, vol. 8(3), pp. 148-150.
Folkman et al., 1976, Sci. Am., vol. 234, pp. 58-64.
Shin et al., 2000, Cornea, vol. 19(2), pp. 212-217.
Colorado et al., 2000, Cancer Res., vol. 60, pp. 2520-2526).
Wassberg, Ups. J. Med. Sci., 1999, vol. 104(1):1-24, (Abstract).
Di Bisceglie et al., Hepatology, 1998, vol. 28(4):1161-1165.
Buckley et al., ORL J. Otorhinolaryngol.Relat. Spec., Jul.-Aug. 2001, vol. 63(4):259-264.
Auerbach and Auerbach, Pharmacol. Ther. 63(3):265-311 (1994).
Bagri et al., Neuron 33(2):233-48 (2002).
Biochemistry 11:1726 (1972).
Brantley et al., Oncogene 21:7011-26 (2002).
Brose et al., Cell (1999) 96(6):795-806.
Liu et al., Biochem. Biophys. Res. Commun. (2001) 286:281-291.
Ma et al., J. Biol. Chem. (1994) 269:27739-27746.
Yuan et al., Dev. Biol. (1999) 212(2):290-306.
International Search Report for PCT/US03/07458, mailed on Mar. 9, 2006, 5 pages.
Wang et al., Cancer Cell (2003) 4(1):19-29.
Werner et al., J. Cancer Res. Clin. Oncol. (2001) 127:207-216.
Gordon et al., J. of Clin. Oncology (2001) 19(3):843-850.
Supplementary Partial European Search Report for EP 03716469.6, date mailed on Apr. 5, 2007, 5 pages.
EPO Communication (Office Action) dated Dec. 6, 2010, issued by the European Patent Office in related European Patent Application No. EP-03716469.6 (3 pages).
Kemmerer Elizabeth C.
Osha • Liang LLP
Shanghai Institutes for Biological Sciences CAS
Xie Xiaozhen
LandOfFree
Detection and modulation of slit and roundabount (robo)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection and modulation of slit and roundabount (robo)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection and modulation of slit and roundabount (robo)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2655094